Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Non-GAAP net income attributable to Gilead by Quarter
Non-GAAP net income (loss) attributable to Gilead ($M) ($M)
Gilead Sciences Non-GAAP net income attributable to Gilead: -$10,496M in Q2 2026, down 635.5% from a year earlier. That is the lowest of the 39 quarters on record here.
Where the Q2 2026 figure comes from
“|| Net (loss) income | $ | (10,496) | $ | 1,960 | $ | (8,475) | $ | 3,275”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-08-04) ↗
Reported in Form 8-K Reconciliation of GAAP to Non-GAAP Financial Information.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up non-GAAP net income attributable to Gilead
Cite this data
StockData. (2026). Gilead Sciences Non-GAAP net income attributable to Gilead ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/ng-net-inc
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.